Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

Darapladib - CAS# 356057-34-6 205728 1474110-21-8

SKU: 14424205949

4.7
USD130.90 USD171.90

Pay in 4 interest-free payments of $32.73 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 14 - Aug 19

Live Spec

Darapladib - CAS# 356057-34-6 205728 1474110-21-8Darapladib, also known as SB 480848, is a reversible lipoprotein associated phospholipase A2 (Lp PLA2) inhibitor with IC50 of 0. 25 nM, which is in Phase 3 trials. Recent studies showed that risk of major coronary events not reduced by darapladib therapy. In patients with stable coronary heart disease, darapladib did not significantly reduce the risk of the primary composite end point of cardiovascular death, myocardial infarction, or stroke. Product

Store: avramcheva.com · Domain: avramcheva.com

Description

1474110-21-8

2Na/c10-3-4-1-5-6(2-7(4)13(16)17)12-9(15)8(14)11-5

Formula: C10H7KN6O

XPO1 target occupancy measurements confirm the KPT-330recommended phase 2 dose

Di Carlo M

Darapladib - CAS# 356057-34-6 205728 1474110-21-8Darapladib, also known as SB 480848, is a reversible lipoprotein associated phospholipase A2 (Lp PLA2) inhibitor with IC50 of 0. 25 nM, which is in Phase 3 trials. Recent studies showed that risk of major coronary events not reduced by darapladib therapy. In patients with stable coronary heart disease, darapladib did not significantly reduce the risk of the primary composite end point of cardiovascular death, myocardial infarction, or stroke. Product

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products